Martin Ruthardt
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 36
- Chronic Myeloid Leukemia Treatments 35
- Molecular Biology top 2%
- Retinoids in leukemia and cellular processes 26
- Protein Degradation and Inhibitors 16
- Cell death mechanisms and regulation 9
- Histone Deacetylase Inhibitors Research 8
- Biochemistry top 2%
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 22
- Oncology top 5%
-
- Acute Lymphoblastic Leukemia research 10
- Co-authors
- Elena PuccettiOliver G. OttmannClara NerviPier Giuseppe PelicciF GrignaniDieter HoelzerFausto GrignaniCarla Tribioli
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Martin Ruthardt
85 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Hematology 2.0k
- Molecular Biology 3.2k
- Biochemistry 224
- Genetics 380
- Oncology 547
Countries citing papers authored by Martin Ruthardt
This map shows the geographic impact of Martin Ruthardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Ruthardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Ruthardt more than expected).
Fields of papers citing papers by Martin Ruthardt
This network shows the impact of papers produced by Martin Ruthardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Ruthardt. The network helps show where Martin Ruthardt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martin Ruthardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 5 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 10 | |
| 4 | 2014 | 42 | |
| 5 | 2013 | 53 | |
| 6 | 2012 | 14 | |
| 7 | 2012 | 5 | |
| 8 | 2012 | 24 | |
| 9 | 2011 | 87 | |
| 10 | 2009 | 43 | |
| 11 | 2009 | 38 | |
| 12 | 2009 | 28 | |
| 13 | 2007 | 61 | |
| 14 | 2007 | 40 | |
| 15 | 2006 | 21 | |
| 16 | 2005 | 154 | |
| 17 | 2004 | 7 | |
| 18 | 2003 | 32 | |
| 19 | 2003 | 16 | |
| 20 | 1998 | 473 |
About Martin Ruthardt
Martin Ruthardt is a scholar working on Hematology, Genetics and Molecular Biology, having authored 85 papers that have together received 3.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (36 papers), Chronic Myeloid Leukemia Treatments (35 papers), Retinoids in leukemia and cellular processes (26 papers), Chronic Lymphocytic Leukemia Research (22 papers), Protein Degradation and Inhibitors (16 papers), Acute Lymphoblastic Leukemia research (10 papers), Cell death mechanisms and regulation (9 papers) and Histone Deacetylase Inhibitors Research (8 papers). The work is most often cited by research in Hematology (2.0k citations), Molecular Biology (3.2k citations) and Biochemistry (224 citations). Martin Ruthardt has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Elena Puccetti, Oliver G. Ottmann, Clara Nervi, Pier Giuseppe Pelicci, F Grignani, Dieter Hoelzer, Fausto Grignani, Carla Tribioli, Daniela Peruzzi and Arthur Zelent. Their work appears in journals such as Nature, Nature Genetics and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.